Results 11 to 20 of about 10,984 (251)
Reumatismo, 2004 Raynaud’s phenomenon (RP) is a vasospastic disorder characterized by episodic color changes of blanching, cyanosis, and hyperemia in response to cold and/or emotional stress. Although most typically noted in the fingers, the circulation of the toes, ears,
S. Zeni, F. Ingegnoli
doaj +6 more sources
Clinical Medicine, 2020 Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of individuals have primary RP; however, Raynaud's can also occur secondary to a broad range of underlying medical conditions and drug therapies.
Haque, Ashraful +1 more
openaire +4 more sources
British Journal of Hospital Medicine, 2019 Raynaud's phenomenon is a common vasospastic condition which carries a significant burden of pain and hand-related disability ( Hughes and Herrick, 2016 ). The prevalence of Raynaud's phenomenon in the general population has been reported to be approximately 5% ( Garner et al, 2015 ).
Devgire, Vikrant +1 more
openaire +3 more sources
Systemic lupus erythematosus and Raynaud's phenomenon [PDF]
Anais Brasileiros de Dermatologia, 2015 : BACKGROUND: Patients with systemic lupus erythematosus seem to belong to different serological and clinical subgroups of the disease. Genetic background can cause the appearance of these subgroups.
Flavia Emilie Heimovski +2 more
doaj +3 more sources
Synchronous Onset of Secondary Raynaud's Phenomenon in Monozygotic Twins
European Journal of Inflammation, 2012 The heritability of primary Raynaud's phenomenon has been reported in previous works. In this paper we describe the simultaneous onset of Raynaud's phenomenon, rapidly evolved in acrocyanosis and diagnosed as secondary Raynaud's phenomenon, observed in ...
A. Riccio, M.G. Sangiolo, G. Tarantino
doaj +2 more sources
Cardiovascular Research, 1989 Raynaud's phenomenon is episodic digital ischemia provoked by cold and emotion; it is associated with other disorders, such as Raynaud's syndrome, especially the connective tissue diseases. Recent information suggests links with Sjögren's syndrome, malignancy, and obstructive vascular disease.
Belch, Jill J. F.; id_orcid
openaire +8 more sources
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's-Like Phenomenon [PDF]
, 2020 The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. Immune checkpoint inhibitor (ICI)-induced immune-related adverse events (irAEs) may affect almost any organ system and occur at any point during therapy.
Shaheen Khan +13 more
openalex +2 more sources
Journal of Scleroderma and Related Disorders, 2003 Raynaud’s phenomenon can be either primary (idiopathic) or secondary to underlying disease including systemic sclerosis. Primary Raynaud’s phenomenon is very common, affecting approximately 3%–5% of the general population. Although much rarer, systemic sclerosis–related Raynaud’s phenomenon can be particularly severe, progressing to digital ulceration ...
Ariane L. Herrick
openalex +5 more sources
The clinical significance of raynaud's phenomenon in systemic lupus erythematosus [PDF]
, 1979 In a prospective study of 226 patients with systemic lupus erythematosus (SLE), 91 patients (40%) had Raynaud's phenomenon. These patients were compared to 135 patients without Raynaud's phenomenon.
Jacob Dimant +5 more
openalex +2 more sources
PLoS ONE, 2022 BackgroundA major unmet need for Systemic Sclerosis (SSc) clinical management is the lack of biomarkers for the early diagnosis of patients with Raynaud's Phenomenon at high risk of evolving into SSc.ObjectiveTo identify proteins contained within serum ...
Sonsoles Piera-Velazquez +4 more
doaj +1 more source